Apr 30, 2025 | False Claims Act, Health Care, Health Care Fraud
On April 29, 2025, the U.S. Department of Justice (United States Attorney’s Office, Southern District of New York) announced that pharmaceutical giant Gilead Sciences agreed to pay a whopping $202 Million to resolve a False Claims Act investigation. At issue...
Feb 2, 2025 | False Claims Act, federal investigations, Fraud Investigations, Government Investigations
On February 1, 2025, President Trump announced the imposition of substantial tariffs on goods imported from Canada, Mexico, and China. These tariffs are likely to come with an increase in customs enforcement, with customs officials ensuring that incoming goods are...
Jan 31, 2025 | Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, White Collar Crime
Earlier this month, the Department of Justice announced that it had indicted the Chesapeake Regional Medical Center (CRMC) with healthcare fraud and conspiracy in relation to unnecessary gynecological and other procedures performed by one of its employed physicians....
Oct 14, 2024 | False Claims Act, Health Care, Health Care Fraud, White Collar Crime
On October 10, 2024, the DOJ announced that Teva Pharmaceuticals had agreed to pay $450 million to resolve two matters, one of which was the result of an investigation conducted pursuant to the False Claims Act (FCA). According to the DOJ, the settlement encompasses...
Jun 27, 2024 | Criminal Matters, federal investigations, SEC Investigations, White Collar Crime
This week, the Supreme Court issued a flurry of important decisions, including two major decisions related to white collar criminal enforcement, both which deal significant blows to the government. Snyder v. United States – Supreme Court Significantly Limits Scope of...
